Giacomo Centenaro: I Arrived to Represent My Country and Community at WFH 2026
Giacomo Centenaro, Project Manager at Crafted, shared on LinkedIn:
”Four days at WFH Congress 2026 have come to an end.
I arrived carrying the responsibility of representing my country and my patient community.
I’m leaving with something I didn’t fully anticipate: a clearer perspective on how closely my professional world connects to this one.
I live with a bleeding disorder, but I also work as a project manager in a communication agency, where my focus is on shaping messages, aligning stakeholders, and turning complex topics into something people can actually understand and act on.
Usually, these two parts of my life don’t overlap. This week in Kuala Lumpur, they did.
Being surrounded by patients, clinicians, researchers, caregivers, and policymakers from more than 130 countries felt, in many ways, familiar.
Not because of the context, but because of the dynamics: different voices, different priorities, and a shared goal that only works if communication is clear, aligned, and effective.
You hear about breakthroughs in gene therapy and advances in treatment, but you also hear stories from those who still lack access to basic care.
And it becomes evident that the gap isn’t just scientific – it’s about how information is shared, how priorities are communicated, and how advocacy is built and sustained over time.
That’s where I recognized my role. Because beyond science, progress depends on narratives, on the ability to connect people, and on making complex realities understandable and actionable.
It’s not just about innovation—it’s about how that innovation is communicated, perceived, and ultimately delivered.
Grateful to Fedemo for this opportunity, and to the World Federation of Hemophilia and the Hemophilia Society of Malaysia for bringing this global community together.”
Stay updated with Hemostasis Today.
-
Nov 18, 2026, 01:45Shikha Jha: My Takeaways from the 4th GANSID International Congress
-
Nov 18, 2026, 01:34Zeeshan Ahmed Khattak: Treatment of Fever and Neutropenia in Hematology/Oncology and Hematopoietic Cell Transplant Patients
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support